SAVIENT PHARMACEUTICALS INC 4
4 · SAVIENT PHARMACEUTICALS INC · Filed Jan 26, 2009
Insider Transaction Report
Form 4
Lamm Robert
SVP, Quality & Reg. Affairs
Transactions
- Award
Common Stock, $0.1 par value per share
2008-08-31$11.35/sh+967$10,973→ 49,829 total - Sale
Common Stock, $0.1 par value per share
2009-01-22$6.10/sh−2,230$13,606→ 48,862 total - Award
Common Stock, $0.1 par value per share
2008-02-29$11.35/sh+905$10,269→ 50,734 total
Footnotes (2)
- [F1]These shares were sold automatically pursuant to a binding contract under Rule 10b5-1 of the Securities Exchange Act of 1934, to cover tax withholding obligations in connection with the vesting of restricted stock granted on January 21, 2005.
- [F2]Consists of shares acquired pursuant to the Savient Pharmaceuticals, Inc. 1998 Employee Stock Purchase Plan, which were not previously reported on a Form 4.